Substance Abuse Treatment Clinician Opinions and Infectious Disease Service Delivery

Overview

Journal J Addict Dis

Publisher Informa Healthcare

Date 2009 Feb 7

PMID 19197590

Citations 7

Authors

Kathlene Tracy

Lawrence S Brown

Steven Kritz

Donald Alderson

Jim Robinson

Edmund J Bini

Michael Levy

Donald Calsyn

Traci Rieckmann

Bret Fuller

Pat McAuliffe

John Rotrosen

Affiliations

Soon will be listed here.

Abstract

Substance abuse treatment programs are an important platform for delivery of services for infectious diseases associated with drug and alcohol use. However, important components of infectious disease care are not universally provided. Clinician training often focuses on information about infectious diseases and less attention is paid to provider opinions and attitudes that may be barriers to providing infectious diseases services. In a national multi-site trial conducted by the National Drug Abuse Treatment Clinical Trials Network (CTN), we investigated the relationship between clinician opinions and the delivery of services for human immunodeficiency virus, hepatitis C virus, and sexually transmitted infections in substance abuse treatment settings. Survey data were collected from 1,723 clinicians at 269 CTN treatment programs. Clinician opinion was found to be significantly related to infectious disease service delivery. Implications for training are discussed.

Citing Articles

Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.

OHara G, Liberman A, Polonsky M, Azbel L, Marcus R, Doltu S J Subst Abuse Treat. 2021; 136:108660.

PMID: 34801282 PMC: 10879837. DOI: 10.1016/j.jsat.2021.108660.

The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.

Bojko M, Mazhnaya A, Marcus R, Makarenko I, Islam Z, Filippovych S J Subst Abuse Treat. 2016; 66:37-47.

PMID: 27211995 PMC: 4919997. DOI: 10.1016/j.jsat.2016.03.003.

Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.

Polonsky M, Azbel L, Wickersham J, Taxman F, Grishaev E, Dvoryak S Drug Alcohol Depend. 2015; 148:47-55.

PMID: 25620732 PMC: 4330127. DOI: 10.1016/j.drugalcdep.2014.12.008.

Community Providers' Impression of HIV Prevention Intervention Research in NIDA's Clinical Trials Network.

Campbell A, Hartzler B, Hatch-Maillette M, Calsyn D, Miele G, Tross S J Drug Issues. 2013; 41(4):441-446.

PMID: 23293393 PMC: 3536537. DOI: 10.1177/002204261104100401.

Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

Talal A, Dimova R, Seewald R, Peterson R, Zeremski M, Perlman D J Subst Abuse Treat. 2012; 44(1):115-9.

PMID: 22405884 PMC: 4440681. DOI: 10.1016/j.jsat.2012.01.010.

References

Grossman H . Addressing the need for HIV specialists: the AAHIVM perspective. AIDS Read. 2006; 16(9):479-86. View

Edlin B, Kresina T, Raymond D, Carden M, Gourevitch M, Rich J . Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis. 2005; 40 Suppl 5:S276-85. PMC: 1510897. DOI: 10.1086/427441. View

Strauss S, Astone J, Vassilev Z, Des Jarlais D, Hagan H . Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat. 2003; 24(4):291-7. DOI: 10.1016/s0740-5472(03)00037-0. View

Strauss S, Falkin G, Vassilev Z, Des Jarlais D, Astone J . A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002; 22(2):55-62. DOI: 10.1016/s0740-5472(01)00213-6. View

Vassilev Z, Strauss S, Astone J, Des Jarlais D . Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs. J Behav Health Serv Res. 2004; 31(2):208-16. DOI: 10.1007/BF02287383. View